Cesar Egoavil, MD
Clinical Cardiac Electrophysiology · Marietta, GANPI 1942279328
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,068 of the $17,215 with a category attached, or 75.9%. 31 manufacturers reported payments, led by Medtronic at 38.7% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in GA, where the typical reported total is $21,716.
Across 437 payments — averaging $39.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Abbott$2K
- Atricure, Inc.$2K
- Boston Scientific$2K
- Johnson & Johnson$530
- E.r. Squibb & Sons, L.L.C.$519
- plus $3K from 25 others
What the payments were for
- Travel & lodging$4,14724%
- Food & beverage$13,06876%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 121 | $6,662 |
| Abbott | 47 | $2,277 |
| Atricure, Inc. | 12 | $2,264 |
| Boston Scientific | 95 | $2,037 |
| Johnson & Johnson | 34 | $530 |
| E.r. Squibb & Sons, L.L.C. | 32 | $519 |
| Pfizer | 25 | $509 |
| EBR Systems, Inc. | 2 | $453 |
| Sanofi-aventis U.S. LLC | 14 | $257 |
| Kestra Medical Technology Services, Inc. | 2 | $197 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $191 |
| Siemens Medical Solutions USA, Inc. | 2 | $176 |
| W. L. Gore & Associates, Inc. | 7 | $154 |
| Elutia, Inc. | 1 | $144 |
| Cardiva Medical, Inc. | 2 | $132 |
| Merck | 6 | $120 |
| Novartis | 5 | $82 |
| Bayer | 4 | $74 |
| Novo Nordisk | 3 | $67 |
| Heartflow, Inc. | 2 | $66 |
| AstraZeneca | 3 | $59 |
| Amgen | 3 | $51 |
| Philips North America LLC | 1 | $36 |
| United Orthopedics LLC | 1 | $30 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Lundbeck LLC | 2 | $26 |
| Convatec Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,802
- EVERA MRI XT DR SURESCAN$927
- Micra$845
- ATRICLIP LAA EXCLUSION SYSTEM$471
- ENSITE PRECISION$401
- JOT DX$328
- ADVISOR$327
- AVEIR$245
- AFFERA MAPPING SYSTEM$192
- SYMPLICITY G3$163
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$158
- ENSITE$157
- COBALT DR MRI SURESCAN$153
- AZURE XT DR MRI SURESCAN$150
- SYNERGY ABLATION SYSTEM$146
- ECM Patch,Pouch$144
- Azure$127
- Assure WCD$124
- AURORA EV-ICD MRI SURESCAN$116
- HeartWare HVAD$112
How this compares
$17,215 in reported general payments places this provider in the 45th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 502 | $572,637 |
| XareltoRivaroxaban | 68 | $86,122 |
| MultaqDronedarone Hcl | 63 | $69,476 |
| Dofetilide | 88 | $14,141 |
| Flecainide Acetate | 129 | $5,458 |
| SotalolSotalol Hcl | 369 | $4,956 |
| Metoprolol Succinate | 266 | $3,533 |
| Amiodarone Hcl | 80 | $2,843 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 11 | $2,625 |
| Nadolol | 13 | $1,383 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 21 | $940 |
| Mexiletine Hcl | 11 | $827 |
| Nebivolol Hcl | 11 | $675 |
| Valsartan | 24 | $500 |
| Digoxin | 19 | $425 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $509 | $572,637502 claims |
| Johnson & JohnsonXarelto | $530 | $86,12268 claims |
| Sanofi-aventis U.S. LLCMultaq | $257 | $69,47663 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Marietta
- Michael RileyMarietta$121K
- Bryan PiedadMarietta$103K
- Narenda KanuruMarietta$34K
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- David NewtonSavannah$225K
- Michael LloydAtlanta$221K
- Kent NilssonAthens$198K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.